The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Ulf Olsson. Portrait.

Ulf Olsson

Professor

Ulf Olsson. Portrait.

Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening

Author

  • L Lindfors
  • P Skantze
  • U Skantze
  • M Rasmusson
  • A Zackrisson
  • Ulf Olsson

Summary, in English

Amorphous drug nanosuspensions are prone to particle growth due to Ostwald ripening. By incorporating a second component of extremely low aqueous solubility, Ostwald ripening can be inhibited. These studies indicate that to inhibit ripening, the drug/inhibitor mixture (in the particles) must form a single phase. The drug/inhibitor mixture can be characterized by the interaction parameter chi using the Bragg-Williams theory, in which single phase mixtures are obtained for chi < 2. The chi parameter can be calculated from the (crystalline) solubility of the drug in the inhibitor, provided the inhibitor is a liquid, and the melting entropy and temperature of the drug.

Department/s

  • Physical Chemistry

Publishing year

2006

Language

English

Pages

906-910

Publication/Series

Langmuir

Volume

22

Issue

3

Document type

Article

Publisher

The American Chemical Society (ACS)

Topic

  • Physical Chemistry (including Surface- and Colloid Chemistry)

Status

Published

ISBN/ISSN/Other

  • ISSN: 0743-7463